Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR)
Condition(s):Polymyalgia RheumaticaLast Updated:March 19, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Polymyalgia RheumaticaLast Updated:March 19, 2024Recruiting
Condition(s):Polymyalgia RheumaticaLast Updated:January 12, 2023Completed
Condition(s):Polymyalgia RheumaticaLast Updated:February 1, 2023Recruiting
Condition(s):Polymyalgia RheumaticaLast Updated:November 29, 2023Recruiting
Condition(s):Polymyalgia RheumaticaLast Updated:May 24, 2023Recruiting
Condition(s):Polymyalgia RheumaticaLast Updated:May 24, 2023Recruiting
Condition(s):Polymyalgia RheumaticaLast Updated:November 22, 2023Recruiting
Condition(s):Polymyalgia RheumaticaLast Updated:August 4, 2023Terminated
Condition(s):Polymyalgia Rheumatica; Effect of Drug; Safety IssuesLast Updated:September 15, 2022Completed
Condition(s):Polymyalgia RheumaticaLast Updated:August 1, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.